|1.||Zhang, Jian: 3 articles (06/2014 - 07/2013)|
|2.||Shi, Shengliang: 2 articles (06/2014 - 07/2013)|
|3.||Chen, Yingdao: 1 article (06/2014)|
|4.||Wang, Jing: 1 article (06/2014)|
|5.||Liu, Huanhuan: 1 article (06/2014)|
|6.||Gao, Huaiqing: 1 article (06/2014)|
|7.||Lin, Hongyu: 1 article (06/2014)|
|8.||Gao, Huai-Qing: 1 article (01/2014)|
|9.||Lin, Xiao-Li: 1 article (01/2014)|
|10.||Shi, Sheng-Liang: 1 article (01/2014)|
12/15/1997 - "In vitro studies demonstrated that overexpression of AD7c-NTP in transfected neuronal cells promotes neuritic sprouting and cell death, the two principal neuroanatomical lesions correlated with dementia in AD. "
04/01/2002 - "In this regard, elevated levels of AD7c-NTP can be detected in both CSF and urine of patients with early or moderately severe AD, and the CSF and urinary levels of AD7c-NTP correlate with the severity of dementia. "
12/15/1997 - "The results suggest that abnormal AD7c-NTP expression is associated with AD neurodegeneration, and during the early stages of disease, CSF levels correlate with the severity of dementia."
12/15/1997 - "CSF levels of AD7c-NTP were correlated with Blessed dementia scale scores (r = 0. "
|2.||Alzheimer Disease (Alzheimer's Disease)
06/03/2014 - "[Diagnostic value of AD7C-NTP for patients with mild cognitive impairment due to Alzheimer's disease]."
01/01/2014 - "Accuracy of urinary AD7c-NTP for diagnosing Alzheimer's disease: a systematic review and meta-analysis."
07/01/2013 - "A literature review of AD7c-ntp as a biomarker for Alzheimer's disease."
04/01/2004 - "BLASTX searching revealed that the hypothetical protein is a homolog of AD-associated neuronal thread protein (AD7c-NTP), which is over-expressed in Alzheimer disease (AD) beginning early in the course of disease, and over-expression of the AD7c-NTP gene would cause neuritic sprouting and cell death. "
04/01/2002 - "The AD7c-ntp neuronal thread protein biomarker for detecting Alzheimer's disease."
|4.||Parkinson Disease (Parkinson's Disease)
12/15/1997 - "In CSF samples from individuals with early possible or probable AD, the mean concentration of AD7c-NTP (4.6+/-3.4) was also elevated relative to the levels in CSF from age-matched (1.2+/-0.7) and neurological disease (1.0+/-0.9) controls, and ambulatory patients with Parkinson's disease (1.8+/-1.1) (all P < 0.001). "
12/15/1997 - "Ghanbari, manuscript submitted for publication) constructed with antibodies to the recombinant protein, AD7c-NTP levels were measured under code in 323 clinical and postmortem cerebrospinal fluid (CSF) samples from AD, age-matched control, Parkinson's disease, and neurological disease control patients. "
|1.||Biological Markers (Surrogate Marker)
|2.||Complementary DNA (cDNA)
|4.||DNA Transposable Elements (Element, IS)
|6.||Amyloid (Amyloid Fibrils)